In re Ampicillin Antitrust Litigation

81 F.R.D. 377, 25 Fed. R. Serv. 2d 1248, 202 U.S.P.Q. (BNA) 134, 1978 U.S. Dist. LEXIS 18926
CourtDistrict Court, District of Columbia
DecidedMarch 20, 1978
DocketM.D.L. No. 50; Misc. 45-70
StatusPublished
Cited by60 cases

This text of 81 F.R.D. 377 (In re Ampicillin Antitrust Litigation) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Ampicillin Antitrust Litigation, 81 F.R.D. 377, 25 Fed. R. Serv. 2d 1248, 202 U.S.P.Q. (BNA) 134, 1978 U.S. Dist. LEXIS 18926 (D.D.C. 1978).

Opinion

MEMORANDUM OPINION

CHARLES R. RICHEY, District Judge.

Plaintiffs in these consolidated cases seek discovery of documents which have been identified by the defendants, Beecham Group Limited and Beecham, Inc. (Beecham), in their responses to interrogatories submitted by the plaintiffs. Beech-am, however, refused to produce many of these documents, asserting the protection of the attorney-client privilege.1 Plaintiffs then filed motions to compel production under Fed.R.Civ.P. 37(a). Because these motions involved complicated issues and over 700 documents, the Court appointed a Special Master for the purpose of ruling on these privilege claims.2 The Master has filed four reports, dated June 7, 1974 (Reports IA and IB), July 8, 1975 (Report 9), and August 15,1975 (Report 10), relating to separate groups of documents, to which Beecham has raised both preliminary and substantive objections. These reports are now before the Court for review.3

[381]*381In its responses to the reports, Beecham has raised two preliminary objections. First, Beecham contends that the Master’s Reports should not be treated as “findings of fact” because the Court’s referral order only stated that the Master was to make “recommendations.” Second, Beecham asserts that Reports IA and IB are invalid because the Master failed to hold evidentia-ry hearings. For the reasons hereinafter set forth in Part II, the Court rejects and overrules these objections.

In addition, Beecham has raised three substantive objections to the Reports. Specifically, it has claimed that the Master, in examining Beecham’s attorney-client privilege claims, erred: (1) in applying the “control group” test to communications involving employees of a corporation; (2) in requiring that a communication must contain confidential information or facts in order for it to be a confidential one; and (3) in refusing to accord the privilege to the communications of a patent agent.

For the reasons hereinafter set forth in Part III, the Court decides not to accept the Master’s conclusions of law, but instead will apply the legal standards articulated in Part III. Therefore, in its rulings on the documents affected by this decision, the Court has not been bound by the Master’s findings of fact. The Court’s findings for these documents are set forth in the accompanying Order under the heading “Reason/Description.”

With respect to all of the other rulings and findings of the Master not expressly modified or rejected in this Memorandum Opinion or the accompanying Order, the Court finds them to be correct both in law and in fact.

I. FACTUAL BACKGROUND

In 1973, the City-County-State plaintiffs (CCS plaintiffs) served on Beech-am interrogatories which included requests for certain documents. Beecham refused to produce numerous documents, claiming that most of them were protected either in whole or in part by the attorney-client privilege. On November 19,1973, the CCS plaintiffs filed an amended motion to compel production of the documents under Fed.R.Civ.P. 37(a), to which Beecham filed a response, accompanied by affidavits, again asserting that the documents were privileged. On January 28, 1974, the Court ordered Beecham to supply a justification for each document or portion thereof that was claimed as privileged. Affidavits and voluminous indices were filed in compliance with this Order. The Court then appointed John D. Lane, Esquire, as Special Master to consider the arguments advanced by the parties, examine the documents in question, and make recommendations on the claims of privilege. The Master filed his first report in two parts, entitled: (1) “Report of the Master on Claims of Attorney-Client Privilege Relative to 443 Documents Claimed Privileged in Their Entirety by Defendant Beecham” (Report IA), and (2) “Report of the Master on Claims of Attorney-Client Privilege for Portions of 302 Documents (Masked Documents) by Defendant Beecham” (Report IB). Beecham asserted a number of objections to these Reports which were opposed by the plaintiffs. Plaintiffs stated that they had no objections of their own to the reports, but then went on to advance a number of arguments they sought to have considered if the Court were to rule in favor of Beecham’s objections.4

[382]*382On October 7, 1974, this Court held a hearing on these reports, and after further consideration of the reports, the Court remanded Reports IA and IB to the Master for reconsideration. On August 8,1975, the Master issued a report entitled “Report on Beecham Documents Held Non-Privileged Under the Control Group Theory” (Report 9). Again, Beecham filed objections and the plaintiffs responded.

On July 31, 1974, plaintiffs filed a supplemental motion to compel production of documents under Fed.R.Civ.P. 37(a) to obtain discovery of some 269 additional documents. The motion challenged the attorney-client privilege claims asserted by Beecham with respect to the documents identified by the defendants in response to additional interrogatories filed by the plaintiffs. This supplemental motion was also referred to the Master, and on August 18, 1975, the Master issued a report entitled “Report on Supplemental Rule 37 Motion Against Beecham Defendants” (Report 10), to which objections were filed by Beecham.

Beecham, in its objections, has not taken issue with the rulings on all of the. 745 documents in Reports IA, IB, and 9. In Report IA, the Master sustained Beecham’s claims as to 320 documents. Of the remaining documents, Beecham has not opposed the Master’s recommendation as to 47 documents, leaving 76 disputed documents which Beecham has identified in the appendix to its July 9, 1974 memorandum. As to Report IB, the Master has recommended that Beecham’s claims of privilege be sustained as to 186 documents. Beecham has disputed the recommendations of the Master as to 74 of the remaining 116 documents. And, as to Report 9, the Master has recommended that Beecham’s claims of privilege be denied on all but one document. Beecham has objected to all of the recommendations contained in this report, except for that document on which its claim was sustained. Of the 269 documents at issue in Report 10, the Master has recommended sustaining Beecham’s privilege claims on 140 of them. Of the remaining 129 documents, Beecham does not object to the recommended denial of the privilege as to 34 documents, leaving 95 documents still in dispute.

The Court will address the two preliminary objections raised by Beecham before considering the objections to the Master’s rulings on the attorney-client privilege claims.5

II. PRELIMINARY OBJECTIONS

Beecham’s first objection involves what standard of review is to be applied to the Master’s reports. Under Fed.R.Civ.P. 53

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Prasad v. George Washington University
District of Columbia, 2017
In Re: Queen's University at Kingston
820 F.3d 1287 (Federal Circuit, 2016)
Goldstein v. Federal Deposit Insurance Corporation
494 B.R. 82 (District of Columbia, 2013)
Oasis International Waters, Inc. v. United States
110 Fed. Cl. 87 (Federal Claims, 2013)
Zander v. Department of Justice
885 F. Supp. 2d 1 (District of Columbia, 2012)
Gucci America, Inc. v. Guess?, Inc.
271 F.R.D. 58 (S.D. New York, 2010)
METZLER CONTRACTING CO. LLC v. Stephens
642 F. Supp. 2d 1192 (D. Hawaii, 2009)
United States v. Naegele
468 F. Supp. 2d 165 (District of Columbia, 2007)
In re Rivastigmine Patent Litigation
237 F.R.D. 69 (S.D. New York, 2006)
Minebea Co. v. Papst
229 F.R.D. 1 (District of Columbia, 2005)
Cobell v. Norton
226 F.R.D. 67 (District of Columbia, 2005)
Banks v. Office of Senate Sergeant-At-Arms
222 F.R.D. 1 (District of Columbia, 2004)
GFL Advantage Fund, Ltd. V. Colkitt
216 F.R.D. 189 (District of Columbia, 2003)
Jones v. United States
828 A.2d 169 (District of Columbia Court of Appeals, 2003)
Yankee Atomic Electric Co. v. United States
54 Fed. Cl. 306 (Federal Claims, 2002)
Aktiebolag v. Andrx Pharmaceuticals, Inc.
208 F.R.D. 92 (S.D. New York, 2002)
State Ex Rel. Stovall v. Meneley
22 P.3d 124 (Supreme Court of Kansas, 2001)
Gorman v. Polar Electro, Inc.
137 F. Supp. 2d 223 (E.D. New York, 2001)
Smithkline Beecham Corp. v. Apotex Corp.
193 F.R.D. 530 (N.D. Illinois, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
81 F.R.D. 377, 25 Fed. R. Serv. 2d 1248, 202 U.S.P.Q. (BNA) 134, 1978 U.S. Dist. LEXIS 18926, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-ampicillin-antitrust-litigation-dcd-1978.